Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Codral Cold & Flu
Active Ingredients: Codeine phosphate, hemihydrate 9.5mg equivalent to 7.03mg codeine
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
Dosage Form: Tablet
New Zealand Sponsor: Johnson & Johnson Pacific (New Zealand) Limited
Manufacturer: Probiotec Pharma Pty Limited, Laverton North, Victoria, Australia
Product: Docetaxel Winthrop
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Infusion Concentrate
Diluent
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Aventis Pharma, Dagenham, Essex, United Kingdom
Pierre Fabre Medicament Production, Etablissement Aquitaine Pharm International, Idron, France
Product: Panadol Cold & Flu Max + Decongestant
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia
Dated this 21st day of November 2008.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).